Xiwang Pharmaceutical technology center is recognized as a national enterprise technology center, the China Glucose Quality Testing Center, and a national laboratory. The enterprise has been approved to establish a post-doctoral research workstation. The self-developed crystalline fructose has broken the monopoly of a few countries such as the United States and Israel on fructose production, and the enterprise has built a domestically leading corn fructose production line. We have realized an upgrade and leap of products from the food-grade to the functional-grade and pharmaceutical-grade.
- Data-driven sourcing and supplier qualification protocols for reliable supply.
- Integrated logistics and inventory management systems for seamless delivery.
- Market intelligence platforms that track trends and identify opportunities.
